This study may additionally support the hypothesis that HFrEF is, in part, a metabolic disease with alterations in fuel signalling proteins such as FGF21 from extracardiac organs such as the liver engendering changes in cardiac energy metabolism. Here, FGF21 is linked to Other metabolic disease.